berberine has been researched along with Ischemic Stroke in 2 studies
Ischemic Stroke: Stroke due to BRAIN ISCHEMIA resulting in interruption or reduction of blood flow to a part of the brain. When obstruction is due to a BLOOD CLOT formed within in a cerebral blood vessel it is a thrombotic stroke. When obstruction is formed elsewhere and moved to block a cerebral blood vessel (see CEREBRAL EMBOLISM) it is referred to as embolic stroke. Wake-up stroke refers to ischemic stroke occurring during sleep while cryptogenic stroke refers to ischemic stroke of unknown origin.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We conducted a meta-analysis to evaluate the clinical efficacy of berberine (BBR) in treating acute ischemic stroke (AIS), explore its anti-inflammatory effects, and assess its potential applications for AIS patients." | 9.41 | Effects of adjuvant berberine therapy on acute ischemic stroke: A meta-analysis. ( Chen, B; Harkare, HV; Huang, B; Luo, D; Ma, T; Pan, J; Shi, S; Song, Y; Sun, S; Wang, L; Yu, B, 2023) |
| "Our previous studies have shown that berberine can improve the nerve function deficits in ischemic stroke by inhibiting inflammation." | 8.31 | Astrocytes-derived exosomes pre-treated by berberine inhibit neuroinflammation after stroke via miR-182-5p/Rac1 pathway. ( Ding, W; Gu, Q; Liu, M; Sun, J; Zhu, J; Zou, J, 2023) |
| "We conducted a meta-analysis to evaluate the clinical efficacy of berberine (BBR) in treating acute ischemic stroke (AIS), explore its anti-inflammatory effects, and assess its potential applications for AIS patients." | 5.41 | Effects of adjuvant berberine therapy on acute ischemic stroke: A meta-analysis. ( Chen, B; Harkare, HV; Huang, B; Luo, D; Ma, T; Pan, J; Shi, S; Song, Y; Sun, S; Wang, L; Yu, B, 2023) |
| "Our previous studies have shown that berberine can improve the nerve function deficits in ischemic stroke by inhibiting inflammation." | 4.31 | Astrocytes-derived exosomes pre-treated by berberine inhibit neuroinflammation after stroke via miR-182-5p/Rac1 pathway. ( Ding, W; Gu, Q; Liu, M; Sun, J; Zhu, J; Zou, J, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, W | 1 |
| Gu, Q | 1 |
| Liu, M | 1 |
| Zou, J | 1 |
| Sun, J | 1 |
| Zhu, J | 1 |
| Luo, D | 1 |
| Yu, B | 1 |
| Sun, S | 1 |
| Chen, B | 1 |
| Harkare, HV | 1 |
| Wang, L | 1 |
| Pan, J | 1 |
| Huang, B | 1 |
| Song, Y | 1 |
| Ma, T | 1 |
| Shi, S | 1 |
1 review available for berberine and Ischemic Stroke
| Article | Year |
|---|---|
Effects of adjuvant berberine therapy on acute ischemic stroke: A meta-analysis.
Topics: Atherosclerosis; Berberine; Carotid Intima-Media Thickness; Humans; Ischemic Stroke; Stroke; Triglyc | 2023 |
1 other study available for berberine and Ischemic Stroke
| Article | Year |
|---|---|
Astrocytes-derived exosomes pre-treated by berberine inhibit neuroinflammation after stroke via miR-182-5p/Rac1 pathway.
Topics: Animals; Apoptosis; Astrocytes; Berberine; Exosomes; Glucose; Inflammation; Ischemic Stroke; Mice; M | 2023 |